Analysts at StockNews.com began coverage on shares of MEI Pharma (NASDAQ:MEIP – Get Free Report) in a report issued on Tuesday. The brokerage set a “buy” rating on the stock. Other equities analysts have also issued research reports about the company. TheStreet lowered MEI Pharma from a “c-” rating to a “d+” rating in a […]
Related Keywords
, Stifel Nicolaus , Cable Car Capital , Exchange Commission , Pharma Inc , Nasdaq , Get Free Report , Car Capital , Free Report , Mei Pharma , Nasdaq Meip , Ameip , Medical , Initiated Coverage , Stocknews Com ,
comparemela.com © 2020. All Rights Reserved.